Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Aiming to prevent further deterioration and leakage of water and sewerage pipes, Aqualiner has developed their Melt in Place Pipe (MIPP). This patented technology consists of a sock insertion, which when heated, expands and melts onto the inner pipe and forms a solid glass-reinforced thermoplastic layer. This process can increase the longevity of existing pipes and is the only product of this type to be approved to be safe-for-use in drinking water pipes. The UK has more than 251,000 miles of water pipes, where almost 75,000 miles of pipes are classed as damaged.
Aqualiner firstly plans to sell the initial equipment in return for a small profit margin, but the materials and consumables used in the process will be sold to the licensed contractor directly as a second income stream. The third source of revenue is derived from fees charged to International territorial licensors for any Aqualiner sales.
The product has been developed with support from Anglian Water, Severn Trent Water and Yorkshire Water and is approved to be installed in US drinking water pipes.
days to go:
Expired
investment:
£642,471
Pomodoro e Basilico are a popular vegan artisan food stall with a loyal following and have been featured by major news outlets and celebrity chefs. They are looking to raise funds to launch London's first Italian, Vegan Deli-Bistro to fill the gap in the market for great, Italian inspired, vegan delis.
days to go:
Expired
investment:
Withheld
The Five Points Brewing Company (TFPBC) is one of London's best-known craft breweries that brews modern, flavourful, craft beer, The company asserts that its beers are stocked nationwide in pubs and across major chains like Waitrose, Tesco and Nando's. TFPBC claims that it has grown from £173,000 worth of sales in 2013 to £4.8 million in 2019. The company's first pub, The Pembury Tavern, has been graced with awards and recommendations from multiple entities. TFPBC argues that it has developed its e-commerce site in the wake of COVID-19 achieving online sales of over £300,000 from selling three million pints in draught, bottle and can form since March 2020. It also won the Champion Beer Of London 2019 Award. The company will use the investment to open its new on-site taproom with a large outdoor area for beer sales direct to the public, build a new flagship brewery site in Hackney, drive new sources of revenue whilst reducing costs, and maintain its commitment to East London
days to go:
Expired
investment:
£841,392
Smoke & Salt is an award-winning, critically acclaimed restaurant that combines the idea for contemporary dining with ancient food storage methods. It is the first restaurant from Smoke & Salt Hospitality Group Ltd and has won many awards including The Cateys ‘Best Newcomer’ restaurant, a 5-star review from Time Out, and it was put 6th on the ‘Top 100 restaurants in London that you have to try’ list. The funds will be used to secure the restaurant site, buy the equipment, fund the fit-out and working capital for the company.
days to go:
Expired
investment:
£154,225
Growth Capital Ventures (GCV) is a Financial Conduct Authority (FCA) approved fintech company. GCV's mission is to back the game changers, innovators and value creators. It is operating at three different levels namely, G-Ventures, a specialist software development division; Quva, a private investor network; and G- Labs, an innovation lab. The company aims to provide investors with access to well researched alternative investment opportunities that are selected for their potential to deliver better returns than traditional mainstream investment products. GCV has structured property transactions worth £14.7 million, has 5000+ everyday investors, and seen 500+ jobs created by portfolio companies. GCV will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
£1,295,410
Harvey’s British Eatery is a 35 to 40 cover eatery focused on re-establishing the heritage of British cooking. Harvey’s recipes draw on the best in the British Isles, using seasonal ingredients. The investment will be used to take their eatery to a permanent site in London.
(SEIS partial)
days to go:
Expired
investment:
£193,550
